155 related articles for article (PubMed ID: 36921731)
1. Impact of iron overload in hematopoietic stem cell transplantation.
Wang C; Zhao M; Liu Q; Yang Y; Li Y; Nie Y; Gao S; Li W
Transpl Immunol; 2023 Jun; 78():101820. PubMed ID: 36921731
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies.
Leitch HA; Fibach E; Rachmilewitz E
Crit Rev Oncol Hematol; 2017 May; 113():156-170. PubMed ID: 28427505
[TBL] [Abstract][Full Text] [Related]
3. Iron Overload Following Hematopoietic Stem Cell Transplantation: Prevalence, Severity, and Management in Children and Adolescents with Malignant and Nonmalignant Diseases.
Cattoni A; Capitoli G; Casagranda S; Corti P; Adavastro M; Molinaro A; Di Gennaro F; Bonanomi S; Biondi A; Galimberti S; Balduzzi A
Transplant Cell Ther; 2023 Apr; 29(4):271.e1-271.e12. PubMed ID: 36708803
[TBL] [Abstract][Full Text] [Related]
4. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.
Kim YR; Kim JS; Cheong JW; Song JW; Min YH
Acta Haematol; 2008; 120(3):182-9. PubMed ID: 19129689
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.
Meyer SC; O'Meara A; Buser AS; Tichelli A; Passweg JR; Stern M
Biol Blood Marrow Transplant; 2013 Mar; 19(3):440-4. PubMed ID: 23089566
[TBL] [Abstract][Full Text] [Related]
7. New insights into transfusion-related iron toxicity: Implications for the oncologist.
Porter JB; de Witte T; Cappellini MD; Gattermann N
Crit Rev Oncol Hematol; 2016 Mar; 99():261-71. PubMed ID: 26806144
[TBL] [Abstract][Full Text] [Related]
8. Current Review of Iron Overload and Related Complications in Hematopoietic Stem Cell Transplantation.
Atilla E; Toprak SK; Demirer T
Turk J Haematol; 2017 Mar; 34(1):1-9. PubMed ID: 27956374
[TBL] [Abstract][Full Text] [Related]
9. Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell Transplant.
Isidori A; Loscocco F; Visani G; Chiarucci M; Musto P; Kubasch AS; Platzbecker U; Vinchi F
Transplant Cell Ther; 2021 May; 27(5):371-379. PubMed ID: 33969823
[TBL] [Abstract][Full Text] [Related]
10. The role of iron in patients after bone marrow transplantation.
de Witte T
Blood Rev; 2008 Dec; 22 Suppl 2():S22-8. PubMed ID: 19059053
[TBL] [Abstract][Full Text] [Related]
11. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
[TBL] [Abstract][Full Text] [Related]
12. Impact of iron overload on poor graft function after allo-HSCT in a patient with transfusion-dependent low-risk MDS: A case report and literature review.
Wang C; Zhao M; Nie Y; Yang Y; Tan Y; Du Z; Gao S; Li W
Medicine (Baltimore); 2022 Dec; 101(51):e32012. PubMed ID: 36595778
[TBL] [Abstract][Full Text] [Related]
13. Effect of iron overload and iron-chelating therapy on allogeneic hematopoietic SCT in children.
Lee JW; Kang HJ; Kim EK; Kim H; Shin HY; Ahn HS
Bone Marrow Transplant; 2009 Dec; 44(12):793-7. PubMed ID: 19398966
[TBL] [Abstract][Full Text] [Related]
14. Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
Armand P; Kim HT; Rhodes J; Sainvil MM; Cutler C; Ho VT; Koreth J; Alyea EP; Hearsey D; Neufeld EJ; Fleming MD; Steen H; Anderson D; Kwong RY; Soiffer RJ; Antin JH
Biol Blood Marrow Transplant; 2011 Jun; 17(6):852-60. PubMed ID: 20854920
[TBL] [Abstract][Full Text] [Related]
15. Results from a 1-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral Deferasirox in patients diagnosed with low and int-1 risk myelodysplastic syndrome (MDS) and transfusion-dependent iron overload.
Nolte F; Höchsmann B; Giagounidis A; Lübbert M; Platzbecker U; Haase D; Lück A; Gattermann N; Taupitz M; Baier M; Leismann O; Junkes A; Schumann C; Hofmann WK; Schrezenmeier H
Ann Hematol; 2013 Jan; 92(2):191-8. PubMed ID: 23073603
[TBL] [Abstract][Full Text] [Related]
16. Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.
Dadwal SS; Tegtmeier B; Liu X; Frankel P; Ito J; Forman SJ; Pullarkat V
Eur J Haematol; 2015 Mar; 94(3):235-42. PubMed ID: 25082161
[TBL] [Abstract][Full Text] [Related]
17. [The role of iron metabolism in myelodysplastic syndromes].
Finelli C; Clissa C; Stanzani M
Recenti Prog Med; 2014 Mar; 105(3):123-6. PubMed ID: 24675455
[TBL] [Abstract][Full Text] [Related]
18. Polycythemia following allogeneic hematopoietic progenitor cell transplantation occurring during iron chelation therapy.
Fedele R; Cuzzola M; Irrera G; Pontari A; D'Ascola DG; Oliva EN; Martino M
Leuk Lymphoma; 2016; 57(4):969-72. PubMed ID: 26308385
[No Abstract] [Full Text] [Related]
19. Iron overload and allogeneic hematopoietic stem-cell transplantation.
Kanda J; Kawabata H; Chao NJ
Expert Rev Hematol; 2011 Feb; 4(1):71-80. PubMed ID: 21322780
[TBL] [Abstract][Full Text] [Related]
20. Progress of iron-chelating therapy for iron overload in patients after bone marrow transplantation.
Li SW; Li X; Guan F
Yi Chuan; 2015 Sep; 37(9):865-72. PubMed ID: 26399526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
